Earlier this month the FDA approved Rexulti (Brexpiprazole) for the treatment of agitation in patients with dementia due to Alzheimer’s. Originally approved as an atypical antipsychotic used for schizophrenia, or an adjunct therapy for major depressive disorder,...
Study Materials For Pharmacists
Free 18 Page PDF On The Most Notable Drug Interactions!
